adMare BioInnovations

What adMare BioInnovations does

adMare BioInnovations is a Vancouver-headquartered, privately held Canadian life sciences company creation engine that builds early-stage biotechnology ventures, operates shared R&D infrastructure, and develops industry-ready scientific and executive talent. Founded as the successor to CDRD (Centre for Drug Research and Development, 2005) and re-launched under the adMare brand in 2019, the organization reports helping create 39 companies that have collectively attracted $2.5 billion in risk capital, achieved $5.8 billion in combined value, and generated approximately 1,000 jobs in Canada.

The core product surface consists of three integrated layers. First, two multi-tenant Innovation Centres in Montreal and Vancouver (with the April 2026 opening of the M4 Innovation Centre adding 30,000 sq ft of new capacity to a base of more than 200,000 sq ft) provide move-in-ready wet-lab and office space, shared services such as analytical chemistry and in vivo pharmacology, and a collaborative ecosystem currently housing 29 resident companies and 370+ employed life sciences professionals. Second, the Tx Accelerator offers preclinical-stage ventures integrated scientific, regulatory, IP, and business development support in exchange for equity-linked financing (convertible notes or SAFEs), supplemented by co-accelerator programs with MaRS Discovery District and OBIO and the AbbVie Biotech Innovators Award for Quebec-based startups. Third, the talent stack (adMare Executive Institute, BIS Program, Experiential Learning) and the adMare Community digital platform (3,500+ life sciences professionals) complete a national platform.

The business model is that of a non-profit life sciences development corporation rather than a commercial enterprise: revenue is reinvested into the Canadian ecosystem, services to portfolio companies are delivered through equity-linked instruments rather than fees, and Innovation Centre lab/office space is offered at subsidized rates. The organization is funded through a combination of government, industry, and philanthropic sources, with no parent company, public listing, or VC/PE ownership identified in the source data. Go-to-market is primarily direct and partnership-driven — engaging academic researchers, entrepreneurs, and institutional investors — with no traditional product marketing or paid acquisition channels.

Name

adMare BioInnovations

Legal name

adMare BioInnovations

Website

https://www.admarebio.com/

Company type

Private

Founded year

2019

Operating status

Operating

Short description

adMare BioInnovations is Canada's national life sciences company creation engine, operating Montreal and Vancouver Innovation Centres, the Tx Accelerator, and talent programs to build, fund, and scale early-stage biotech ventures for the Canadian ecosystem.

Ownership category

akta.pro rank

Product category

Biotech Venture Development & Incubation

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)

akta.pro secondary industries

Makerspace, Innovation Lab & Fab Lab Operations (Tools, Safety, Programming) (EDAEAGAI), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

• Biotech company building
• Life sciences incubator
• Venture creation engine
• Biotech accelerator programs
• Life sciences talent development

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels2 records

Marketing channels8 records

Core offering

adMare BioInnovations operates as Canada's life sciences company creation engine. It provides specialized R&D infrastructure (Innovation Centres in Montreal and Vancouver with over 200,000 sq ft of turnkey lab space), seed capital through equity-based instruments, and commercial and scientific expertise to build investable Canadian life sciences companies. The organization also delivers structured accelerator programs (Tx Accelerator), executive leadership training (Executive Institute), and industry skills programs (BIS Program) to support the Canadian life sciences ecosystem.

Product overview

adMare BioInnovations is Canada's life sciences company creation engine, operating as a multi-service organization rather than a single unified product. The core offering centers on two Innovation Centres (Montreal and Vancouver) providing over 200,000 square feet of turnkey laboratory and office infrastructure for life sciences companies. The Tx Accelerator program supports early-stage ventures with integrated services including scientific guidance, coaching, and business development in exchange for equity financing. Supporting talent development functions include the Executive Institute (leadership training), BIS Program (industry skills), and Experiential Learning. The adMare Community digital platform connects over 2,000 life sciences professionals. Additionally, the AbbVie Biotech Innovators Award partnership provides selected Quebec startups with lab space and mentorship.

Differentiator

Problem solved

Functional benefit

Brands

• Tx Accelerator: adMare supports Canadian start-ups involved in the development of new therapies at the preclinical stage through its Accelerator Program.
• M4 Innovation Centre
• AbbVie Biotech Innovators Award
• adMare Community

Products and services

• Innovation Centres

Quantifiable outcome

• 39 companies created with $2.5B risk capital attracted and $5.8B combined value
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• VoxCell BioInnovationcoreStrategic or Co-development Partner · 13 May 2026VoxCell BioInnovation and adMare BioInnovations entered a research partnership to validate a novel antibody-based immune-modulating therapy using VoxCell's human-relevant vascularized cancer tissue models. The collaboration applies perfusable, immune-competent 3D bioprinted cancer tissue models for preclinical evaluation of next-generation oncology biologics, supporting FDA's push toward more predictive, human-relevant testing and reduced reliance on animal models.
• AbbViecoreStrategic or Co-development Partner · 30 April 2026AbbVie and adMare BioInnovations jointly deliver the AbbVie Biotech Innovators Award, a prize designed to foster innovation and support growth in Quebec's life sciences sector. The award provides winning companies with one year of laboratory and office space at the adMare Innovation Centre in Montreal, access to shared equipment and services, and mentorship from AbbVie's scientific and business leaders. The award targets early-stage biotechnology companies with potential for transformational therapies in AbbVie's therapeutic focus areas including immunology, oncology, neuroscience, and aesthetics.
• Queen's UniversitycoreStrategic or Co-development PartneradMare collaborated with Queen's University researchers including Dr. Martin Petkovich and Dr. Jacob Rullo to advance retinoic acid biology research, resulting in the creation of 26therapeutics Inc. for dry eye disease treatment.
• MaRS Discovery DistrictcoreStrategic or Co-development PartnerThe Mars-adMare Accelerator Experts program brings together mentorship and expertise from both organizations to support therapeutic startup development in Canada's life sciences ecosystem.
• OBIO (Ontario Bioscience Innovation Organization)coreStrategic or Co-development PartneradMare partners with OBIO for the MaRS-adMare Therapeutic Accelerator, supporting biotech innovation across Canada through shared expertise and network access.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• MBC BioLabs: San Francisco Bay Area life sciences incubator offering turnkey lab space and shared equipment to early-stage biotech startups. Operates a comparable rental-based model with similar entrepreneur-focused programming.
• BioBAT Innovation Center: New York City life sciences incubator providing wet-lab and office space to early-stage biotech companies within a multi-tenant model. Direct structural analog to adMare's Innovation Centres with similar tenant and shared-services approach.
• LabCentral: Non-profit life sciences incubator in Cambridge, MA operating shared lab facilities and accelerator programs for early-stage biotech startups. Closest analog to adMare's Innovation Centre model, with move-in-ready wet labs and shared scientific services.
• Alexandria LaunchLabs: Alexandria Real Estate's life sciences startup platform offering turnkey lab space, equipment, and entrepreneurship programming across multiple US sites. Direct competitor in the premium life sciences incubator space market.
• BioEnterprise: Cleveland-based nonprofit bioscience business accelerator that advises and capitalizes healthcare and biotech startups. Runs a portfolio approach similar to adMare with mentoring, capital, and ecosystem development support.
• JLABS (Johnson & Johnson Innovation): Global network of life sciences incubators operated by J&J Innovation, providing no-strings-attached lab space and mentorship to early-stage biotech. Direct competitor in the biotech incubation category with similar shared lab and accelerator offerings.
• BioGenerator: St. Louis-based nonprofit that creates and invests in bioscience companies from university research, providing lab space, seed capital, and company formation expertise. Closely mirrors adMare's "company creation engine" model.

Broad incumbents

• MaRS Discovery District: Toronto-based innovation hub supporting science, health, and tech ventures across broader categories, including a partnership program (MaRS-adMare Accelerator) with adMare. Overlapping mission of building Canadian innovation capacity but with a broader (non-biotech-exclusive) scope.
• Ontario Bioscience Innovation Organization (OBIO): Toronto-based nonprofit industry association supporting Ontario's bioscience sector through ecosystem development. Partners with adMare on the MaRS-adMare Therapeutic Accelerator and pursues adjacent ecosystem-building objectives in Canada.

Regional players

• Francis Crick Institute: London-based biomedical research institute with strong industry partnership and commercialization programming for translating research into therapeutic ventures. Comparable translational and talent-development mission, anchored in the UK rather than Canada.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/adMare_Bio
• YouTubeyoutube.com/channel/UCi_95enEvHqpAQhOf5RDt0w
• LinkedInlinkedin.com/company/admare-bioinnovations

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about adMare BioInnovations